Form 4: Acadia Pharmaceuticals Executive James Kihara Reports Stock Transactions
SEC Form 4 Filing
Principal Accounting Officer James Kihara of Acadia Pharmaceuticals reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Summary
- On February 23, 2025, James Kihara, Principal Accounting Officer of Acadia Pharmaceuticals, reported the vesting of 840 restricted stock units, each representing a contingent right to receive one share of Acadia's common stock.
- Following the vesting, Kihara sold 475 shares of common stock on February 24, 2025, at a price of $19.96 per share to cover withholding taxes and tax-related items.
- After these transactions, Kihara beneficially owns 20,228 shares of Acadia Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine stock sales for tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/23/2022 | Start date for the restricted stock units to vest in four equal annual installments |
| 02/23/2025 | Date of restricted stock units vesting (840 shares) |
| 02/24/2025 | Date of common stock sale (475 shares at $19.96) |
| 02/25/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.